A birth control pill for men? When?

September 26, 2012

When will men have their own birth control pill? Scientists have been predicting the debut of a male pill within 5 years for the last 30 years. The factors accounting for that delay—and new optimism that a male pill will emerge within a decade—are the topic of a story in the current edition of Chemical & Engineering News. C&EN is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.

In the story, Michael M. Torrice, C&EN associate editor, describes the need for a male version of the oral contraceptive pill that revolutionized family planning 50 years ago. For example, there are few choices of contraceptives for , half of all U.S. pregnancies are unintended, and those pregnancies cost state and federal programs about $11 billion annually.

Despite that need, the few pharmaceutical companies working to develop a male pill have discontinued research during the last five years. The story explains the scientific and regulatory hurdles in developing new contraceptives and describes promising new research on so-called non-hormonal male contraceptives.

Explore further: Guys, take note: Male birth control pill may be ready soon

More information: "Hunt for the Male Pill: Scientists Search for a Drug that Can Reversibly Derail Sperm Production": cen.acs.org/articles/90/i39/Hu … -Pill-Continues.html

Related Stories

Guys, take note: Male birth control pill may be ready soon

September 5, 2012
Attention men: The day may be coming soon when you can take your own birth control pill with no side effects, according to a study done by a group of scientists that includes a Texas A&M University researcher.

Gradual bone reduction seen in some pill users

July 19, 2011
Birth control pills may reduce a woman's bone density, according to a study published online July 13 in The Journal of Clinical Endocrinology and Metabolism by Group Health Research Institute (GHRI) scientists. Impacts on ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.